Whole Blood Coagulation Time
"Whole Blood Coagulation Time" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The time required by whole blood to produce a visible clot.
| Descriptor ID |
D014914
|
| MeSH Number(s) |
E01.370.225.625.115.950 E05.200.625.115.950 G09.188.960
|
| Concept/Terms |
Whole Blood Coagulation Time- Whole Blood Coagulation Time
- Blood Coagulation Time, Whole
- Coagulation Time, Whole Blood
- Activated Coagulation Time, Whole Blood
|
Below are MeSH descriptors whose meaning is more general than "Whole Blood Coagulation Time".
Below are MeSH descriptors whose meaning is more specific than "Whole Blood Coagulation Time".
This graph shows the total number of publications written about "Whole Blood Coagulation Time" by people in this website by year, and whether "Whole Blood Coagulation Time" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Whole Blood Coagulation Time" by people in Profiles.
-
Liveris A, Bello RA, Friedmann P, Duffy MA, Manwani D, Killinger JS, Rodriquez D, Weinstein S. Anti-factor Xa assay is a superior correlate of heparin dose than activated partial thromboplastin time or activated clotting time in pediatric extracorporeal membrane oxygenation*. Pediatr Crit Care Med. 2014 Feb; 15(2):e72-9.
-
Garvin S, FitzGerald DC, Despotis G, Shekar P, Body SC. Heparin concentration-based anticoagulation for cardiac surgery fails to reliably predict heparin bolus dose requirements. Anesth Analg. 2010 Oct; 111(4):849-55.
-
Lee MS, Rametta S, Aragon J, Khan A, Wilentz J, Singh V, Levitt H, Kamra A, Valania G, Makkar R. New heparin dosing regimen for diabetics undergoing percutaneous coronary intervention. J Invasive Cardiol. 2005 May; 17(5):248-50.
-
Rabah M, Mason D, Muller DW, Hundley R, Kugelmass AD, Weiner B, Cannon L, O'Neill WW, Safian RD. Heparin after percutaneous intervention (HAPI): a prospective multicenter randomized trial of three heparin regimens after successful coronary intervention. J Am Coll Cardiol. 1999 Aug; 34(2):461-7.
-
Jones DR, Hill RC, Vasilakis A, Hollingsed MJ, Graeber GM, Gustafson RA, Cruzzavala JL, Murray GF. Safe use of heparin-coated bypass circuits incorporating a pump-oxygenator. Ann Thorac Surg. 1994 Apr; 57(4):815-8; discussion 818-9.